Meeting
2023 ASCO Genitourinary Cancers Symposium
Germline mutational profile in metastatic urothelial malignancy.
Authors
Emily Barry
Lifespan Cancer Institute, Providence, RI
Emily Barry , Andre Luiz De Souza , Sheldon L. Holder , Galina Lagos , Anthony E. Mega , Benedito A. Carneiro , Ali Amin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 550)
DOI
10.1200/JCO.2023.41.6_suppl.550
Abstract #
550
Poster Bd #
M13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
First Author: Tanya Jindal
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari
Poster
2024 ASCO Genitourinary Cancers Symposium
Comprehensive genomic profiling (CGP) of squamous cell carcinoma of unknown primary (SCCUP) presenting with inguinal, pelvic, and retroperitoneal (I/P/RP) metastases.
First Author: Stephanie Lakritz
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular genetic sequencing of neuroendocrine tumors of the gastrointestinal tract.
First Author: Alexandra Androsova